TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Nattopharma AS
Closing information (x1000 SEK)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover |
193,072
|
221,603
|
204,723 |
Financial expenses |
-157,019
|
995
|
-19,718 |
Earnings before taxes |
162,474
|
-11,844
|
42,052 |
Total assets |
290,362
|
234,813
|
244,069 |
Current assets |
213,100
|
131,588
|
119,800 |
Current liabilities |
189,585
|
76,732
|
63,366 |
Equity capital |
97,675
|
148,167
|
173,648 |
- share capital |
66,720
|
64,714
|
56,825 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency |
33.6%
|
63.1%
|
71.1% |
Turnover per employee | |||
Profit as a percentage of turnover |
84.2%
|
-5.3%
|
20.5% |
Return on assets (ROA) |
1.9%
|
-4.6%
|
9.2% |
Current ratio |
112.4%
|
171.5%
|
189.1% |
Return on equity (ROE) |
166.3%
|
-8.0%
|
24.2% |
Change turnover |
-35,398
|
1,686
|
79,532 |
Change turnover % |
-15%
|
1%
|
64% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.